Key result
Natural products show therapeutic potential against renal cell carcinoma via apoptosis induction and angiogenesis inhibition.
Why the study?
No reviews have been published classifying and summarizing the mechanisms of action of various natural products against renal cell carcinoma.
Do natural products have therapeutic potential in the treatment of renal cell carcinoma?
Do natural products have therapeutic potential in the treatment of renal cell carcinoma?
Natural products exhibit multiple anti-cancer mechanisms in renal cell carcinoma models, suggesting potential as therapeutic candidates.
Hypothesis-generating for natural products in renal cell carcinoma; requires prospective trials before any clinical consideration.
Renal cell carcinoma (RCC) is a common cancer of the urinary system. The potential therapeutic effects of certain natural products against renal cell carcinoma have been reported both in vivo and in vitro, but no reviews have been published classifying and summarizing the mechanisms of action of various natural products. In this study, we used PubMed and Google Scholar to collect and screen the recent literature on natural products with anti-renal-cancer effects. The main mechanisms of action of these products include the induction of apoptosis, inhibition of angiogenesis, inhibition of metastasis and reduction of drug resistance. In total, we examined more than 30 natural products, which include kahweol acetate, honokiol, englerin A and epigallocatechin-3-gallate, among others, have demonstrated a variety of anti-renal-cancer effects. In conclusion, natural products may have a wider application in kidney cancer than previously believed and are potential candidates for treatment in RCC.
No takes yet. Share an insight, caveat, or question.
Feng et al. (2022) conducted a review in Renal cell carcinoma. Natural products was evaluated. Natural products demonstrate potential therapeutic effects against renal cell carcinoma through mechanisms including apoptosis induction, angiogenesis inhibition, metastasis inhibition, and drug sensitization.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: